Clinical trials: Nutritional Biomarkers
Diabetes Mellitus, Type 2
The Effect of Linagliptin (BI 1356) on 24h-glucose Control and Various Biomarkers in Type 2 Diabetic Patients
The objective of this study is to investigate the effect of BI 1356 on 24-h glucose control and various pharmacodynamic parameters in type 2 diabetic patients with inadequate glycaemic control.
- Trial name
- NCT00716092
- Testing
- Sitagliptin, Linagliptin
- Where
- 3 sites in Germany
- Volunteers
- 121 people
- Sponsor
- Boehringer Ingelheim
Dietary Exposure, Diabetes Mellitus, Type 2
Cohort Study on Plant-based Diets (COPLANT Study)
The Cohort on Plant-based Diets (COPLANT) study is a multi-centre cohort study that starts baseline recruitment from 2024 to 2027 with approximately 6,000 participants in Germany and Austria.
- Conditions
- Dietary Exposure, Diabetes Mellitus, Type 2, Cardiovascular Diseases, Bone Loss
- Trial name
- COPLANT (NCT06323538)
- Where
- 8 sites in Austria, Germany
- Volunteers
- 6,000 people
- Sponsor
- German Federal Institute for Risk Assessment
Metabolic Syndrome
Evaluating the Tolerability and Effects of Berberine on Major Metabolic Biomarkers: A Pilot Study
Berberine is a dietary supplement that comes from the roots, stems, and bark of various plants and has been used for centuries in traditional Chinese medicine.
- Trial name
- NCT03976336
- Testing
- Berberine
- Where
- United States
- Volunteers
- 15 people
- Sponsor
- University of Kansas Medical Center
Prader-Willi Syndrome
Characterization of Serum Proteome in Subjects With Prader Willi Syndrome (PROTEOMARKER)
The lack of serum markers that can be used to identify the levels of steatosis in obese subjects, or that can indicate a rapid progression of the metabolic disease, in which it is very often difficult to perform analyzes with…
- Trial name
- PROTEOMARKER (NCT05761184)
- Testing
- Serum collection for proteomic analysis
- Where
- Italy
- Volunteers
- 52 people
- Sponsor
- Istituto Auxologico Italiano
Obesity
Dietary Lipids, Energy Expenditure and Obesity Biomarkers
The purpose of this study is to determine whether the modulation of dietary lipids are effective in the treatment of obesity and comorbidities.
- Trial name
- NCT02656940
- Testing
- Group 1 - diet rich in n-3 and n-6 PUFA, Group 2 - diet rich in MUFA
- Volunteers
- 32 people
- Sponsor
- Universidade Federal do Rio de Janeiro
Diet Interventions, Diabetes Mellitus
Correlation Between Dietary Patterns, Anthropometric Profiles, Genetic Profiles, and Biomarker Levels to Diabetes
The goal of this clinical trial is to explore the correlation between dietary patterns, anthropometric measurements, genetic profiles, and biomarker levels and their impact on glucose levels and other relevant biomarkers in…
- Trial name
- NCT07800884
- Testing
- diet intervention
- Where
- Indonesia
- Volunteers
- 181 people, healthy volunteers welcome
- Sponsor
- Universitas Indonesia
Amyotrophic Lateral Sclerosis
Staging System in Amyotrophic Lateral Sclerosis
Recently two staging systems have been proposed for amyotrophic lateral sclerosis (ALS), based on clinical milestones The King's college clinical staging system (1) and ALS Milano-Torino Staging (ALS-MITOS) (2).
- Trial name
- Biostaging (NCT04858555)
- Where
- 2 sites in France
- Volunteers
- 50 people
- Sponsor
- University Hospital, Limoges
Type 2 Diabetes
Renal Effects of DPP-4 Inhibitor Linagliptin in Type 2 Diabetes
The aim of this study is to detail the (mechanisms underlying the) actions of the DPP-4 inhibitor linagliptin on the renal system in patients with type 2 diabetes mellitus.
- Trial name
- RENALIS (NCT02106104)
- Testing
- Linagliptin 5 mg QD (N=24), Glimepiride 1 mg QD (N=24)
- Where
- Netherlands
- Volunteers
- 48 people
- Sponsor
- Amsterdam UMC, location VUmc
Dehydration
Reference Values and Determinants of Hydration in Children 3-13 y
Purpose: 1. Develop reference values for hydration biomarkers for children of 3 to 13 years old 2. Explore the association between children's and parents' hydration markers and fluid intake habits in children aged 3-13 y 3.
- Trial name
- HYBISKUS (NCT02937038)
- Where
- United States
- Volunteers
- 1,454 people, healthy volunteers welcome
- Sponsor
- Arizona State University
Iron Overload, Hemochromatosis
Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content
The purpose of this multi-site research is to validate a rapid magnetic resonance based confounder-corrected R-2 mapping method as a quantitative imaging biomarker of liver iron concentrations.
- Conditions
- Iron Overload, Hemochromatosis, Hemosiderosis
- Trial name
- NCT02025543
- Testing
- MRI
- Where
- 4 sites in United States
- Volunteers
- 207 people, healthy volunteers welcome
- Sponsor
- University of Wisconsin, Madison
Type 1 Diabetes
Biomarkers of Heterogeneity in Type 1 Diabetes
Biomarkers of heterogeneity in type 1 diabetes: establishment of a biobank and an integrated approach to clinical and metabolic phenotyping of individuals with established T1DM.
- Trial name
- NCT04977635
- Where
- 3 sites in Netherlands
- Volunteers
- 611 people
- Sponsor
- Diabeter Nederland BV
Alzheimer's Disease, Multiple Sclerosis
A Biospecimen and Clinical Data Study on Patients for Drug & Biomarker Discovery
The purpose of this research project is to collect and store blood samples and clinical data. Researchers can then use the stored samples in future studies.
- Conditions
- Alzheimer's Disease, Multiple Sclerosis, Parkinson's Disease, Huntington's Disease
- Trial name
- NCT01592552
- Where
- United States
- Volunteers
- 20 people, healthy volunteers welcome
- Sponsor
- Sanguine Biosciences
Obesity
Impact of Body Weight and Weight Loss on Drug Bioavailability, Cardiovascular Risk Factors and Metabolic Biomarkers
Drug bioavailability and disposition vary according to body weight and weight loss after bariatric surgery. This study evaluates the impact of body weight and weight loss on the pharmacokinetics of various probe drugs, and…
- Trial name
- COCKTAIL (NCT02386917)
- Testing
- Gastric bypass, Very low calorie diet
- Where
- Norway
- Volunteers
- 100 people
- Sponsor
- The Hospital of Vestfold
Metabolic Dysfunction-Associated Liver Disease
Type 2 DIAbeTes With NAFLD: innOvative Biomarkers of Disease progressioN and clInical outComes
Type 2 diabetes (T2DM) patients are at high-risk for advanced fibrosis (AF) due to non-alcoholic fatty liver disease (NAFLD), recently renamed Metabolic dysfunction-Associated Liver Disease (MASLD).
- Trial name
- DIATONIC (NCT06567990)
- Testing
- Non-invasive test for the screening of MASLD-related advanced fibrosis in patients with T2D.
- Where
- 4 sites in France
- Volunteers
- 500 people
- Sponsor
- Hospices Civils de Lyon
Major Depressive Disorder (MDD), Schizophenia Disorder
Prospective Observational Study of the Relationship Between Sociodemographic Factors, Blood-based Biomarkers and Psychiatric Symptoms in Neurodegenerative Diseases and Mental Disorders
This is a prospective observational study to identify sociodemographic factors that predict mental health outcomes in the European population and provide evidence linking common, modifiable sociodemographic risk factors for…
- Conditions
- Major Depressive Disorder (MDD), Schizophenia Disorder, Bipolar 1 Disorder, Alzheimer Disease
- Trial name
- Synapsing-SD (NCT07239843)
- Where
- Spain
- Volunteers
- 1,310 people, healthy volunteers welcome
- Sponsor
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Fabry Disease, Cardiac Variant, Right Ventricular Hypertrophy
Myocardial Affectation in Patients With Fabry Disease Without Phenotypic Manifestation. Diagnostic Value of Biomarkers
The cardiac variant of the Fabry disease is a rare cardiomyopathy affecting 1/50000 individuals in general population. It is generally diagnosed in advanced stages of the disease, because it presents clinical features very…
- Trial name
- FAMY (NCT01442350)
- Volunteers
- 120 people
- Sponsor
- Francisco Marín Ortuño
Vascular Disease, Endothelial Dysfunction
Effects of Almonds on Vascular Reactivity in Patients With Coronary Artery Disease
This is a study of the effects of 3 oz almonds added daily to a National Cholesterol Education Program Therapeutic Lifestyle Changes (TLC) diet in improving endothelial function in patients with Coronary Artery Disease.
- Conditions
- Vascular Disease, Endothelial Dysfunction, Heart Disease, Cardiovascular Diseases
- Trial name
- NCT00782015
- Testing
- Almonds
- Where
- United States
- Volunteers
- 45 people
- Sponsor
- Tufts University
Obesity
How Does Bariatric Surgery Affect Social Experiences and Well-being - The BaSES-study
Nonrandomized controlled trial to assess whether or not sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB) affect social experiences and biomarkers of well-being 6 weeks and 1 year after surgery.
- Trial name
- BaSES (NCT05207917)
- Testing
- Gastric bypass, Sleeve gastrectomy, Single anastomosis sleeve ileal (SASI) bypass
- Where
- Norway
- Volunteers
- 134 people, healthy volunteers welcome
- Sponsor
- The Hospital of Vestfold
RETT Syndrome With Proven MECP2 Mutation
Osteoporosis in RETT Syndrome
Based on our clinical observations, many girls with RETT syndrome, a severe neuro-developmental encephalopathy, suffer from osteoporosis which can appear at a very early age (before age 10) and can lead to fractures, pain and a…
- Trial name
- OSRETT (NCT02110797)
- Testing
- biological markers and evaluation of the mineral density at the lumber spine using DEXA
- Where
- France
- Volunteers
- 98 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Friedreich Ataxia
A Study to Assess Variation in Potential Biomarkers in Friedreich Ataxia
To test the variability of specific ribonucleic acid (RNA) and proteins as well as frataxin levels in samples of blood and buccal cells taken directly from patients with Friedreich's ataxia (FRDA) in order to confirm potential…
- Trial name
- NCT04255680
- Testing
- Buccal Swabs and Blood Draws
- Where
- United States
- Volunteers
- 20 people
- Sponsor
- Larimar Therapeutics, Inc.